Search
satavaptan
Not yet FDA approved.
Indications:
- presumably SIADH
Dosage: 12.5-50 mg PO
Mechanism of action:
- vasopressin V2 receptor antagonist
- increases urine volume, decreases urine osmolality
General
vasopressin receptor antagonist (vaptan)